lentinan has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Q; Cai, Y; Wang, H; Xie, D; Yu, J; Zheng, Y | 1 |
| Chen, S; Li, M; Li, WW; Liu, HJ; Liu, YR; Qin, Y; Sheng, PZ; Sun, B; Sun, T; Tian, YX; Wang, LM; Yang, C; Zhou, HG; Zhu, GH; Zong, SM | 1 |
| Hamuro, J; Kikuchi, T; Suzuki, M; Takatsuki, F | 1 |
1 review(s) available for lentinan and Disease Exacerbation
| Article | Year |
|---|---|
Efficacy of biological response modifier lentinan with chemotherapy for advanced cancer: a meta-analysis.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Humans; Immunologic Factors; Lentinan; Neoplasm Staging; Neoplasms; Publication Bias; Survival Analysis; Treatment Failure; Treatment Outcome | 2017 |
2 other study(ies) available for lentinan and Disease Exacerbation
| Article | Year |
|---|---|
Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition.
Topics: A549 Cells; Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Progression; Epithelial-Mesenchymal Transition; HEK293 Cells; Humans; Lentinan; MCF-7 Cells; Melanoma, Experimental; Mice; Neoplasm Metastasis; NIH 3T3 Cells; Polysaccharides; Selenium; Xenograft Model Antitumor Assays | 2018 |
Cancer cell progression and chemoimmunotherapy--dual effects in the induction of resistance to therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Avian Sarcoma Viruses; Combined Modality Therapy; Cyclophosphamide; Dinoprostone; Disease Progression; Drug Resistance, Neoplasm; Female; Fibrosarcoma; Fluorouracil; Immunotherapy; Interleukin-2; Lentinan; Mice; Mice, Inbred Strains; Transforming Growth Factor beta | 1996 |